IHEP OpenIR  > 多学科研究中心
Safety of Nanoparticles in Medicine
Wolfram, J; Zhu, MT; Yang, Y; Shen, JL; Gentile, E; Paolino, D; Fresta, M; Nie, GJ; Chen, CY; Shen, HF; Ferrari, M; Zhao, YL; Zhao YL(赵宇亮)
2015
Source PublicationCURRENT DRUG TARGETS
ISSN1389-4501
EISSN1873-5592
Volume16Issue:14Pages:1671-1681
Corresponding Author赵宇亮
SubtypeArticle
AbstractNanomedicine involves the use of nanoparticles for therapeutic and diagnostic purposes. During the past two decades, a growing number of nanomedicines have received regulatory approval and many more show promise for future clinical translation. In this context, it is important to evaluate the safety of nanoparticles in order to achieve biocompatibility and desired activity. However, it is unwarranted to make generalized statements regarding the safety of nanoparticles, since the field of nanomedicine comprises a multitude of different manufactured nanoparticles made from various materials. Indeed, several nanotherapeutics that are currently approved, such as Doxil and Abraxane, exhibit fewer side effects than their small molecule counterparts, while other nanoparticles (e.g. metallic and carbon-based particles) tend to display toxicity. However, the hazardous nature of certain nanomedicines could be exploited for the ablation of diseased tissue, if selective targeting can be achieved. This review discusses the mechanisms for molecular, cellular, organ, and immune system toxicity, which can be observed with a subset of nanoparticles. Strategies for improving the safety of nanoparticles by surface modification and pretreatment with immunomodulators are also discussed. Additionally, important considerations for nanoparticle safety assessment are reviewed. In regards to clinical application, stricter regulations for the approval of nanomedicines might not be required. Rather, safety evaluation assays should be adjusted to be more appropriate for engineered nanoparticles.
KeywordNanomedicine nanoparticle nanosafety nanotoxicity safety toxicity
Subject AreaPharmacology & Pharmacy
DOI10.2174/1389450115666140804124808
Indexed BySCI
Language英语
WOS Research AreaPharmacology & Pharmacy
WOS SubjectPharmacology & Pharmacy
WOS IDWOS:000365624900012
Citation statistics
Document Type期刊论文
Identifierhttp://ir.ihep.ac.cn/handle/311005/228840
Collection多学科研究中心
Recommended Citation
GB/T 7714
Wolfram, J,Zhu, MT,Yang, Y,et al. Safety of Nanoparticles in Medicine[J]. CURRENT DRUG TARGETS,2015,16(14):1671-1681.
APA Wolfram, J.,Zhu, MT.,Yang, Y.,Shen, JL.,Gentile, E.,...&赵宇亮.(2015).Safety of Nanoparticles in Medicine.CURRENT DRUG TARGETS,16(14),1671-1681.
MLA Wolfram, J,et al."Safety of Nanoparticles in Medicine".CURRENT DRUG TARGETS 16.14(2015):1671-1681.
Files in This Item:
File Name/Size DocType Version Access License
793.pdf(1360KB)期刊论文作者接受稿限制开放CC BY-NC-SAApplication Full Text
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Wolfram, J]'s Articles
[Zhu, MT]'s Articles
[Yang, Y]'s Articles
Baidu academic
Similar articles in Baidu academic
[Wolfram, J]'s Articles
[Zhu, MT]'s Articles
[Yang, Y]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Wolfram, J]'s Articles
[Zhu, MT]'s Articles
[Yang, Y]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.